{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T05:23:35Z","timestamp":1678598615924},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10637-022-01212-y","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T12:03:04Z","timestamp":1641902584000},"page":"576-585","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenformin increases early hematopoietic progenitors in the Jak2V617F murine model"],"prefix":"10.1007","volume":"40","author":[{"given":"Ant\u00f4nio Bruno","family":"Alves-Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna Alves","family":"Fenerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha Peixoto","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaqueline Cristina","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luiz","family":"Coelho-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Antonio","family":"Pereira-Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago Mantello","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Santos","family":"Scheucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Magalh\u00e3es","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Chahud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena L\u00f4bo","family":"Figueiredo-Pontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Traina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"1212_CR1","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2017) WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, 4a Edi\u00e7\u00e3o. Lyon"},{"key":"1212_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","volume":"6","author":"DAMESHEK W,","year":"1951","unstructured":"DAMESHEK W (1951) Some speculations on the myeloproliferative syndromes. Blood 6:372\u2013375","journal-title":"Blood"},{"key":"1212_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ et al (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054\u20131061. https:\/\/doi.org\/10.1016\/S0140-6736(05)71142-9","journal-title":"Lancet"},{"key":"1212_CR4","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS et al (2005) A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders. N Engl J Med 352:1779\u20131790. https:\/\/doi.org\/10.1056\/NEJMoa051113","journal-title":"N Engl J Med"},{"key":"1212_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J et al (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387\u2013397. https:\/\/doi.org\/10.1016\/j.ccr.2005.03.023","journal-title":"Cancer Cell"},{"key":"1212_CR6","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Cou\u00e9dic J-P et al (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434:1144\u20131148. https:\/\/doi.org\/10.1038\/nature03546","journal-title":"Nature"},{"key":"1212_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fendo.2017.00361","volume":"8","author":"SR Hubbard","year":"2018","unstructured":"Hubbard SR (2018) Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase. Front Endocrinol (Lausanne) 8:361. https:\/\/doi.org\/10.3389\/fendo.2017.00361","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1212_CR8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199602293340906","volume":"334","author":"CJ Bailey","year":"1996","unstructured":"Bailey CJ, Turner RC (1996) Metformin. N Engl J Med 334:574\u2013579. https:\/\/doi.org\/10.1056\/NEJM199602293340906","journal-title":"N Engl J Med"},{"key":"1212_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1158\/1940-6207.CAPR-10-0175","volume":"3","author":"M Pollak","year":"2010","unstructured":"Pollak M (2010) Metformin and Other Biguanides in Oncology: Advancing the Research Agenda. Cancer Prev Res 3:1060\u20131065. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-10-0175","journal-title":"Cancer Prev Res"},{"key":"1212_CR10","doi-asserted-by":"publisher","unstructured":"Neto EMR, Marques LARV, Ferreira MAD et al (2015) Metformina: Uma Revis\u00e3o da Literatura. Sa\u00fade e Pesqui 8:355\u2013362. https:\/\/doi.org\/10.17765\/2176-9206.2015V8N2P355-362","DOI":"10.17765\/2176-9206.2015V8N2P355-362"},{"key":"1212_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.taap.2008.08.013","volume":"233","author":"JA Dykens","year":"2008","unstructured":"Dykens JA, Jamieson J, Marroquin L et al (2008) Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicol Appl Pharmacol 233:203\u2013210. https:\/\/doi.org\/10.1016\/j.taap.2008.08.013","journal-title":"Toxicol Appl Pharmacol"},{"key":"1212_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz EM, Baquero P, Michie AM et al (2017) Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat Med 23:1234\u20131240. https:\/\/doi.org\/10.1038\/nm.4399","journal-title":"Nat Med"},{"key":"1212_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.exphem.2016.08.005","volume":"44","author":"I Kawashima","year":"2016","unstructured":"Kawashima I, Kirito K (2016) Metformin inhibits JAK2V617F activity in MPN cells by activating AMPK and PP2A complexes containing the B56\u03b1 subunit. Exp Hematol 44:1156-1165.e4. https:\/\/doi.org\/10.1016\/j.exphem.2016.08.005","journal-title":"Exp Hematol"},{"key":"1212_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41419-017-0256-4","volume":"9","author":"JA Machado-Neto","year":"2018","unstructured":"Machado-Neto JA, Fenerich BA, Scopim-Ribeiro R et al (2018) Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death Dis 9:311. https:\/\/doi.org\/10.1038\/s41419-017-0256-4","journal-title":"Cell Death Dis"},{"key":"1212_CR15","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1182\/blood-2019-132115","volume":"134","author":"JL Coelho-Silva","year":"2019","unstructured":"Coelho-Silva JL, Bianco TM, Silva ABA et al (2019) Metformin Suppress Cellular and Molecular Processes Related to Maintenance and Proliferation of Myeloproliferative Neoplasm Stem Cell. Blood 134:1682\u20131682. https:\/\/doi.org\/10.1182\/blood-2019-132115","journal-title":"Blood"},{"key":"1212_CR16","doi-asserted-by":"publisher","first-page":"E534","DOI":"10.1002\/ijc.29193","volume":"136","author":"S Orecchioni","year":"2015","unstructured":"Orecchioni S, Reggiani F, Talarico G et al (2015) The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells. Int J Cancer 136:E534\u2013E544. https:\/\/doi.org\/10.1002\/ijc.29193","journal-title":"Int J Cancer"},{"key":"1212_CR17","doi-asserted-by":"publisher","unstructured":"Somlyai G, Collins TQ, Meuillet EJ et al (2017) Structural homologies between phenformin, lipitor and gleevec aim the same metabolic oncotarget in leukemia and melanoma. Oncotarget 8:50187\u201350192. https:\/\/doi.org\/10.18632\/oncotarget.16238","DOI":"10.18632\/oncotarget.16238"},{"key":"1212_CR18","doi-asserted-by":"publisher","first-page":"18226","DOI":"10.1073\/pnas.1317577110","volume":"110","author":"P Yuan","year":"2013","unstructured":"Yuan P, Ito K, Perez-Lorenzo R et al (2013) Phenformin enhances the therapeutic benefit of BRAFV600E inhibition in melanoma. Proc Natl Acad Sci 110:18226\u201318231. https:\/\/doi.org\/10.1073\/pnas.1317577110","journal-title":"Proc Natl Acad Sci"},{"key":"1212_CR19","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.3892\/mmr.2018.8573","volume":"17","author":"S Hu","year":"2018","unstructured":"Hu S, Ouyang Q, Cheng Q et al (2018) Phenformin inhibits cell proliferation and induces cell apoptosis and autophagy in cholangiocarcinoma. Mol Med Rep 17:6028\u20136032. https:\/\/doi.org\/10.3892\/mmr.2018.8573","journal-title":"Mol Med Rep"},{"key":"1212_CR20","doi-asserted-by":"publisher","unstructured":"Guo Z, Zhao M, Howard EW et al (2017) Phenformin inhibits growth and epithelial-mesenchymal transition of ErbB2-overexpressing breast cancer cells through targeting the IGF1R pathway. Oncotarget 8. https:\/\/doi.org\/10.18632\/oncotarget.19466","DOI":"10.18632\/oncotarget.19466"},{"key":"1212_CR21","doi-asserted-by":"publisher","unstructured":"Velez J, Pan R, Lee JTC et al (2016) Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport. Oncotarget 7:51435\u201351449. https:\/\/doi.org\/10.18632\/oncotarget.9843","DOI":"10.18632\/oncotarget.9843"},{"key":"1212_CR22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.celrep.2019.03.067","volume":"27","author":"D Vara-Ciruelos","year":"2019","unstructured":"Vara-Ciruelos D, Dandapani M, Russell FM et al (2019) Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia\/Lymphoma via Cell-Autonomous AMPK Activation. Cell Rep 27:690-698.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.067","journal-title":"Cell Rep"},{"key":"1212_CR23","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1158\/1078-0432.CCR-18-0177","volume":"24","author":"SR Veiga","year":"2018","unstructured":"Veiga SR, Ge X, Mercer CA et al (2018) Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTOR. Clin Cancer Res 24:3767\u20133780. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0177","journal-title":"Clin Cancer Res"},{"key":"1212_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.bbrc.2011.09.134","volume":"414","author":"ED Segal","year":"2011","unstructured":"Segal ED, Yasmeen A, Beauchamp M-C et al (2011) Relevance of the OCT1 transporter to the antineoplastic effect of biguanides. Biochem Biophys Res Commun 414:694\u2013699. https:\/\/doi.org\/10.1016\/j.bbrc.2011.09.134","journal-title":"Biochem Biophys Res Commun"},{"key":"1212_CR25","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.bbrc.2006.05.026","volume":"345","author":"A-M Lamhonwah","year":"2006","unstructured":"Lamhonwah A-M, Tein I (2006) Novel localization of OCTN1, an organic cation\/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun 345:1315\u20131325. https:\/\/doi.org\/10.1016\/j.bbrc.2006.05.026","journal-title":"Biochem Biophys Res Commun"},{"key":"1212_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1177\/106002809302701004","volume":"27","author":"ME McGuinness","year":"1993","unstructured":"McGuinness ME, Talbert RL (1993) Phenformin-Induced Lactic Acidosis: A Forgotten Adverse Drug Reaction. Ann Pharmacother 27:1183\u20131187. https:\/\/doi.org\/10.1177\/106002809302701004","journal-title":"Ann Pharmacother"},{"key":"1212_CR27","doi-asserted-by":"publisher","unstructured":"WILLIAMS RH (1975) Farewell to Phenformin for Treating Diabetes Mellitus. Ann Intern Med 83:567. https:\/\/doi.org\/10.7326\/0003-4819-83-4-567","DOI":"10.7326\/0003-4819-83-4-567"},{"key":"1212_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00745143","volume":"13","author":"M Nattrass","year":"1977","unstructured":"Nattrass M, Todd PG, Hinks L et al (1977) Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics. Diabetologia 13:145\u2013152. https:\/\/doi.org\/10.1007\/BF00745143","journal-title":"Diabetologia"},{"key":"1212_CR29","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.drudis.2018.01.018","volume":"23","author":"NC Baker","year":"2018","unstructured":"Baker NC, Ekins S, Williams AJ, Tropsha A (2018) A bibliometric review of drug repurposing. Drug Discov Today 23:661\u2013672. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.018","journal-title":"Drug Discov Today"},{"key":"1212_CR30","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.2147\/OTT.S168981","volume":"11","author":"Y Wang","year":"2018","unstructured":"Wang Y, Meng Y, Zhang S et al (2018) Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo. Onco Targets Ther 11:6039\u20136048. https:\/\/doi.org\/10.2147\/OTT.S168981","journal-title":"Onco Targets Ther"},{"key":"1212_CR31","first-page":"119","volume":"22","author":"DE Cook","year":"1978","unstructured":"Cook DE (1978) The effects of phenformin in normal vs. diabetic isolated perfused rat liver. Res Commun Chem Pathol Pharmacol 22:119\u2013134","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"1212_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF01219423","volume":"14","author":"G Dietze","year":"1978","unstructured":"Dietze G, Wicklmayr M, Mehnert H et al (1978) Effect of phenformin on hepatic balances of gluconeogenic substrates in man. Diabetologia 14:243\u2013248. https:\/\/doi.org\/10.1007\/BF01219423","journal-title":"Diabetologia"},{"key":"1212_CR33","first-page":"5","volume":"5","author":"JL Schlienger","year":"1979","unstructured":"Schlienger JL, Frick A, Marbach J et al (1979) Effects of biguanides on the intermediate metabolism of glucose in normal and portal-strictured rats. Diabete Metab 5:5\u20139","journal-title":"Diabete Metab"},{"key":"1212_CR34","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1073\/pnas.1702576114","volume":"114","author":"Y-R Shih","year":"2017","unstructured":"Shih Y-R, Kang H, Rao V et al (2017) In vivo engineering of bone tissues with hematopoietic functions and mixed chimerism. Proc Natl Acad Sci 114:5419\u20135424. https:\/\/doi.org\/10.1073\/pnas.1702576114","journal-title":"Proc Natl Acad Sci"},{"key":"1212_CR35","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature14242","volume":"518","author":"K Busch","year":"2015","unstructured":"Busch K, Klapproth K, Barile M et al (2015) Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature 518:542\u2013546. https:\/\/doi.org\/10.1038\/nature14242","journal-title":"Nature"},{"key":"1212_CR36","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1182\/BLOOD-2015-11-683490","volume":"128","author":"Q-S Zhang","year":"2016","unstructured":"Zhang Q-S, Tang W, Deater M et al (2016) Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice. Blood 128:2774. https:\/\/doi.org\/10.1182\/BLOOD-2015-11-683490","journal-title":"Blood"},{"key":"1212_CR37","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1182\/blood-2021-153598","volume":"138","author":"JA Pollard","year":"2021","unstructured":"Pollard JA, Furutani EM, Liu S et al (2021) Metformin for Treatment of Cytopenias in Children and Young Adults with Fanconi Anemia. Blood 138:1102\u20131102. https:\/\/doi.org\/10.1182\/blood-2021-153598","journal-title":"Blood"},{"key":"1212_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/sj.leu.2401608","volume":"14","author":"K Uozumi","year":"2000","unstructured":"Uozumi K, Otsuka M, Ohno N et al (2000) Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles. Leukemia 14:142\u2013152. https:\/\/doi.org\/10.1038\/sj.leu.2401608","journal-title":"Leukemia"},{"key":"1212_CR39","doi-asserted-by":"publisher","DOI":"10.3791\/2809","author":"M Koulnis","year":"2011","unstructured":"Koulnis M, Pop R, Porpiglia E et al (2011) Identification and Analysis of Mouse Erythroid Progenitors using the CD71\/TER119 Flow-cytometric Assay. J Vis Exp. https:\/\/doi.org\/10.3791\/2809","journal-title":"J Vis Exp"},{"key":"1212_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/cyto.a.20674","volume":"75A","author":"GA Challen","year":"2009","unstructured":"Challen GA, Boles N, Lin K-YK, Goodell MA (2009) Mouse hematopoietic stem cell identification and analysis. Cytom Part A 75A:14\u201324. https:\/\/doi.org\/10.1002\/cyto.a.20674","journal-title":"Cytom Part A"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-022-01212-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-022-01212-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-022-01212-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:42:26Z","timestamp":1678509746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-022-01212-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1212"],"URL":"https:\/\/doi.org\/10.1007\/s10637-022-01212-y","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving animals were approved and were following recommendations from Ethical Committee for Animal Research from University of S\u00e3o Paulo at Ribeir\u00e3o Preto Medical School (183\/2018) and followed by Grimace scale for assessing pain in mice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study did not involved human participants. Studies involving animals were approved by Ethical Committee for Animal Research from University of S\u00e3o Paulo at Ribeir\u00e3o Preto Medical School (183\/2018).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human Participants and\/or Animals"}},{"value":"Ant\u00f4nio Bruno Alves-Silva declares that he has no competing interests. Bruna Alves Fenerich declares that she has no competing interests. Natasha Peixoto Fonseca declares that she has no competing interests. Jaqueline Cristina Fernandes declares that she has no competing interests. Juan Luiz Coelho-Silva declares that he has no competing interests. Diego Antonio Pereira-Martins declares that he has no competing interests. Thiago Mantello Bianco declares that he has no competing interests. Priscila Santos Scheucher declares that she has no competing interests. Eduardo Magalh\u00e3es Rego declares that he has no competing interests. Fernando Chahud declares that he has no competing interests. Jo\u00e3o Agostinho Machado-Neto declares that he has no competing interests. Lorena L\u00f4bo Figueiredo-Pontes declares that she has no competing interests. Fabiola Traina declares that she has no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}